GSK to pay $3bn, plead guilty for promoting antidepressants
The largest health care fraud settlement in US history involves criminal and civil violations involving ten drugs. The company will also plead guilty for not reporting the safety
Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus (ocrelizumab) to treat multiple sclerosis (MS).